- Issuer ticker
-
CSBR
- Reported as of
-
05 Nov 2026
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
4
- Accepted by SEC
-
09 Nov 2026, 16:39:27 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Daniel Mendelson
Filing notes and source
Key filing fact
Daniel Newman Mendelson filed Form 4 for CHAMPIONS ONCOLOGY, INC. (CSBR) on 09 Nov 2026.
Key facts
- This page summarizes Daniel Newman Mendelson's Form 4 filing for CHAMPIONS ONCOLOGY, INC. (CSBR).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 09 Nov 2026, 16:39.
Change
- Previous filing in this sequence was filed on 07 Nov 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001327897
Primary reporting owner
Mendelson Daniel Newman
- Relationship
-
Director
- Address
- C/O CHAMPIONS ONCOLOGY, INC., ONE UNIVERSITY PLAZA, SUITE 307, HACKENSACK
- Signature
- /s/ Daniel Mendelson
- Signature date
- 09 Nov 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CSBR
transaction
Derivative
Option to purchase Common Stock
Award
- Transaction value
- Shares
- +20,291
- Change %
- Price
-
$4.76*
- Shares after
- 20,291
- Date
- 05 Nov 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,291
- Exercise price
- $4.76
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote